IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.30 per share which missed the analyst consensus estimate of $3.40 by 2.94 percent. This is a 14.98 percent increase over earnings of $2.87 per share from the same period last year. The company reported quarterly sales of $1.141 billion which beat the analyst consensus estimate of $1.109 billion by 2.92 percent. This is a 14.28 percent increase over sales of $998.427 million the same period last year.